Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

COVID-19

Manufacture Vaccines

The Next Wave of RNA Therapeutics

| Pirkko Muhonen, Sirat Sikka | 6 min read

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.

Business & Regulation Profession

Change Is the Only Constant

| Angus Stewart | 9 min read

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

Manufacture Contract Manufacturing Services

Adversity, Adaption, Delivery, Expansion

| Sponsored by PCI | 8 min read

How one CDMO navigated the pandemic and came out on top of industry trends

Business & Regulation COVID-19

Enter the Weird World of Anti-Vaxxers

| Stephanie Sutton | 3 min read

Why, oh why, is there so much nonsense and misinformation about COVID-19 vaccines?

Manufacture Bioprocessing - Upstream & Downstream

Delving into the Trends of the Biopharma Industry

| Stephanie Sutton

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.

Business & Regulation COVID-19

From COVID-19 to Monkeypox

| Stephanie Sutton

It’s been a busy time for infectious disease vaccine news in Europe.

Business & Regulation Profession

COVID-19: The Lessons We Have Learned

| Stephanie Sutton | 8 min read

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?

Discovery & Development Drug Discovery

Reaching for the Moon

| Angus Stewart | 6 min read

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2

Business & Regulation COVID-19

VIDEO: From Quality Control to Cold Chain

| Sponsored by Dätwyler

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

Business & Regulation Trends & Forecasts

How COVID-19 Saved Pfizer’s Revenue

| Stephanie Sutton | 3 min read

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register